Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Sees Significant Increase in Short Interest

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) was the recipient of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 406,500 shares, a growth of 202.2% from the February 13th total of 134,500 shares. Approximately 2.0% of the shares of the stock are sold short. Based on an average daily volume of 469,300 shares, the short-interest ratio is currently 0.9 days.

Rapid Micro Biosystems Price Performance

Shares of RPID stock opened at $2.46 on Friday. The company has a market capitalization of $106.36 million, a price-to-earnings ratio of -2.20 and a beta of 1.08. Rapid Micro Biosystems has a one year low of $0.58 and a one year high of $4.04. The company’s fifty day moving average price is $2.26 and its 200-day moving average price is $1.41.

Rapid Micro Biosystems (NASDAQ:RPID) last announced its quarterly earnings data on Friday, February 28th. The company reported ($0.22) EPS for the quarter, meeting the consensus estimate of ($0.22). The firm had revenue of $8.22 million for the quarter, compared to the consensus estimate of $8.20 million. Rapid Micro Biosystems had a negative net margin of 184.93% and a negative return on equity of 48.05%. Equities research analysts expect that Rapid Micro Biosystems will post -1.1 earnings per share for the current fiscal year.

Institutional Trading of Rapid Micro Biosystems

A number of institutional investors and hedge funds have recently bought and sold shares of RPID. Millennium Management LLC increased its holdings in Rapid Micro Biosystems by 17.6% in the 4th quarter. Millennium Management LLC now owns 61,375 shares of the company’s stock valued at $55,000 after acquiring an additional 9,191 shares during the last quarter. Citadel Advisors LLC bought a new stake in Rapid Micro Biosystems in the 4th quarter valued at $65,000. Finally, Renaissance Technologies LLC increased its holdings in Rapid Micro Biosystems by 122.9% in the 4th quarter. Renaissance Technologies LLC now owns 183,087 shares of the company’s stock valued at $165,000 after acquiring an additional 100,942 shares during the last quarter. 52.60% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, KeyCorp initiated coverage on shares of Rapid Micro Biosystems in a research report on Wednesday, February 12th. They set an “overweight” rating and a $8.00 price objective on the stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.